Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crocs, Inc. (CROX) vs Kenvue Inc. Common Stock (KVUE) Price & Performance

Crocs, Inc.Trade
Kenvue Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Crocs, Inc. vs Kenvue Inc. Common Stock — how do they compare? Crocs, Inc. trades at $116.68 (market cap $5.53B), while Kenvue Inc. Common Stock trades at $17.88 (market cap $33.67B). The key difference: Kenvue Inc. Common Stock is far larger — about 6.1× Crocs, Inc.'s market cap, and Kenvue Inc. Common Stock pays a 4.79% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.

CROXKVUE
Market Cap
$5.53B$33.67B
Volume
967,17611,878,502
Sector
Consumer CyclicalConsumer Staples
52-Week High
$141.19$19.83
52-Week Low
$73.39$14.11
Typical Hold Time
96 Days—
Enterprise Value
$7.04B$41.17B
Dividend Yield
—4.79%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crocs, Inc.

Crocs (CROX) trades at $116.84, down 2.81% today, amid bearish technical signals but strong fundamental valuation metrics. The stock shows attractive P/E of 10.23 and P/S of 1.46, with robust profitability margins including 57.47% gross margin and 42.3% ROE. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $4.55 surpassing the $4.35 estimate. The company maintains strong cash flow generation despite a net loss in 2025, with management focusing on product innovation and HEYDUDE brand repositioning.

CROX presents a compelling value opportunity with discounted valuation multiples relative to historical performance, though near-term technical weakness and competitive pressures warrant caution. Analyst consensus remains bullish with $136.78 price target representing 17% upside potential. Key risks include consumer discretionary spending sensitivity and execution challenges with brand diversification initiatives. The stock's current levels offer entry points for long-term investors seeking exposure to a profitable footwear company with strong brand recognition.

Kenvue Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CROX
100% Buy0% Sell
Avg holding period · 96 Days
KVUE

No sentiment data available yet.

Top news

Latest headlines on both assets

About Crocs, Inc.

Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.

Read more on CROX →

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →